| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2025 | 25 Mar 2025 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 Outcome of Board Meeting held today i.e., May 27, 2025 for the quarter and financial year ended March 31, 2025 (As Per BSE Announcement dated on 27.05.2025) | ||
| Board Meeting | 31 Jan 2025 | 8 Jan 2025 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board meeting held today i.e January 31, 2025 pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 of the Company (As Per BSE Announcement Dated on: 31/01/2025) | ||
| Board Meeting | 18 Dec 2024 | 18 Dec 2024 |
| Outcome of the Meeting of the board of directors held on December 18, 2024 | ||
| Board Meeting | 12 Nov 2024 | 10 Oct 2024 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended September 30 2024. Outcome of the Board Meeting held on November 12, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement dated on 12/11/2024) | ||
| Board Meeting | 2 Aug 2024 | 27 Jun 2024 |
| Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024.under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Trading Window Closure under SEBI (Prohibition of Insider Trading)Regulations 2015 Outcome of Board Meeting held on August 2, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement dated on 02.08.2024) | ||
| Board Meeting | 1 Jul 2024 | 1 Jul 2024 |
| Outcome of Board Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 | ||
Invesco Mutual Fund and Kotak Mahindra Mutual Fund bought 2.6% apiece, while Franklin Templeton Mutual Fund purchased 1.3% stake.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
